Grünenthal

Grünenthal is a global pharmaceutical company headquartered in Aachen, Germany. Founded in 1946, the company originally focused on antibiotics and later expanded its research and development into pain management, and other therapeutic areas. Grünenthal is a privately owned, family-run business.

The company's primary therapeutic areas of focus include pain, inflammation, and gynecology. Grünenthal has been involved in the development and marketing of various pharmaceutical products, with a significant presence in Europe and Latin America. Their research and development efforts aim to discover and develop innovative medicines for unmet medical needs.

Grünenthal operates through subsidiaries and partnerships in numerous countries worldwide. The company emphasizes innovation, research, and patient well-being as core principles. They are also involved in various initiatives related to corporate social responsibility and sustainable business practices. Grünenthal's history includes both periods of significant growth and product innovation, as well as facing challenges and controversies common within the pharmaceutical industry.